Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Shanghai Junshi Biosciences (1877 HK)
Watchlist
213
Analysis
Health Care
•
China
Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Thematic (Sector/Industry)
•
04 Jul 2021 09:06
China Healthcare Weekly (July.2)
The article analyzed the new document about the development of TCM and western medicine,potential start time of VBP on biosimilar...
Xinyao (Criss) Wang
Follow
235 Views
Share
bearish
•
3SBio Inc
•
29 Jun 2021 09:09
3SBio Inc (1530.HK) - The Concerns and the Outlook
This insight mainly analyzed the potential reasons behind the decline in 3SBio Group's share price, the important products, the pipeline, the...
Xinyao (Criss) Wang
Follow
245 Views
Share
bullish
•
Thematic (Sector/Industry)
•
27 Jun 2021 08:56
China Healthcare Weekly (Jun.25)
This article analyzed the results of 5th national volume-based purchase, the new announcement on the centralized procurement of artificial joints,...
Xinyao (Criss) Wang
Follow
219 Views
Share
bullish
•
Hutchmed China Ltd
•
22 Jun 2021 08:38
Pre-IPO Hutchmed China Ltd (13.HK) - The Strength and the Concerns
The article analyzed Hutchmed in terms of its business analysis, financial performance, pipeline, comparison with other biotech companies, and also...
Xinyao (Criss) Wang
Follow
263 Views
Share
bearish
•
Thematic (Sector/Industry)
•
20 Jun 2021 08:59
China Healthcare Weekly (Jun.18)
The article analyzed the 2021 medical insurance catalogue adjustment plan, new document to crack down on illegal medical beauty activities, new...
Xinyao (Criss) Wang
Follow
203 Views
Share
First
Previous
26
27
28
29
30
31
32
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x